Literature DB >> 28661975

Interleukin-6 Serum Levels Correlate With Severity of Burn Injury but Not With Gender.

Stephan Hager1, Ann Christina Foldenauer2, Hans-Oliver Rennekampff3, Robert Deisz4, Ruedger Kopp4, Mayer Tenenhaus5, Marx Gernot4, Norbert Pallua6.   

Abstract

Gender-specific differences in the outcome of patients with burn injury have been recognized in the past with female patients being at a higher risk of mortality. We hypothesized that early post-burn interleukin-6 (IL-6) cytokine levels may contribute to the different gender-specific outcome. We retrospectively examined 94 burned patients who were treated in the Burn Intensive Care Unit at the University Hospital Aachen. Age, gender, presence of inhalation injury, depth, TBSA, and clinical outcome were documented. Serum samples for IL-6 analysis were collected within 24 hours posttrauma. The relationship between IL-6 levels, gender, survival, and abbreviated burn severity index score was investigated. Male patients (64.9%; n = 61) presented a higher median TBSA (26%) than female patients (20%). The mortality rate of male patients (27.9%; n = 17) and female patients (21.2%; n = 7) was similar. Deceased patients had significant higher TBSA (P = 0.0005) and IL-6 levels (P = 0.0007) than burn survivors. A moderate correlation between IL-6 levels and abbreviated burn severity index score was observed (r = 0.554; P < 0.0001). While TBSA showed a significant influence on IL-6 levels (P = 0.0003), gender did not (P = 0.7395) and inhalation injury indicated a minor influence (P = 0.0780). Only TBSA and age presented a significant influence on mortality (P = 0.0028 and P = 0.0031, respectively). All patients with burn trauma were characterized by elevated IL-6 levels with higher TBSA values resulting in more pronounced levels. Deceased patients had higher initial IL-6 serum levels reflecting higher TBSA and severity. In contrast to other defined trauma mechanisms, gender had no significant influence on postburn IL-6 serum levels and mortality in our patient population.

Entities:  

Year:  2018        PMID: 28661975     DOI: 10.1097/BCR.0000000000000604

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  5 in total

1.  Interleukin-6 blockade, a potential adjunct therapy for post-burn hypermetabolism.

Authors:  Dalia Barayan; Abdikarim Abdullahi; Roohi Vinaik; Carly M Knuth; Christopher Auger; Marc G Jeschke
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.191

2.  Plasma volume expansion and capillary leakage of 20% albumin in burned patients and volunteers.

Authors:  Markus Zdolsek; Robert G Hahn; Folke Sjöberg; Joachim H Zdolsek
Journal:  Crit Care       Date:  2020-05-05       Impact factor: 9.097

3.  Accuracy for Mortality Prediction With Additive Biomarkers Including Interleukin-6 in Critically Ill Patients: A Multicenter Prospective Observational Study.

Authors:  Ryo Yamamoto; Junichi Sasaki; Takayuki Shibusawa; Taka-Aki Nakada; Toshihiko Mayumi; Osamu Takasu; Kenichi Matsuda; Takashi Shimazui; Hiroki Otsubo; Yuto Teshima; Masakazu Nabeta; Takeshi Moriguchi; Shigeto Oda
Journal:  Crit Care Explor       Date:  2021-04-26

4.  A Larger Membrane Area Increases Cytokine Removal in Polymethyl Methacrylate Hemofilters.

Authors:  Tomoyuki Nakamura; Kazuhiro Moriyama; Naohide Kuriyama; Yoshitaka Hara; Satoshi Komatsu; Takahiro Kawaji; Yu Kato; Takuma Ishihara; Ayumi Shintani; Osamu Nishida
Journal:  Membranes (Basel)       Date:  2022-08-22

5.  Distinct Tissue Damage and Microbial Cues Drive Neutrophil and Macrophage Recruitment to Thermal Injury.

Authors:  Francisco Barros-Becker; Jayne M Squirrell; Russell Burke; Julia Chini; Julie Rindy; Aos Karim; Kevin W Eliceiri; Angela Gibson; Anna Huttenlocher
Journal:  iScience       Date:  2020-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.